Phase II study of oral S-1 plus irinotecan in patients with advanced colorectal cancer: Hokkaido Gastrointestinal Cancer Study Group HGCSG0302.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples